PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Czasopismo

2003 | 48 | 4 |

Tytuł artykułu

Progress in development of vaccines against most important gastrointestinal helminth parasites of humans and animals

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
Among many vaccine approaches developed against gastrointestinal helminths in the recent years, parenteral vaccination and use of recombinant helminth antigens expressed in various expression systems have been a major focus. Significant progress has been made towards cloning of protective worm antigens. The recombinant proteins have several benefits over classic vaccine technologies, including increased safety, economy, stability and versatility. Moreover, the identification of site and developmental stage of the parasite in which the expression of genes encoding for potential vaccine antigen become possible using a variety of molecular techniques including hybridization in situ, expressed sequence tags analysis or cDNA microarray technology. Unfortunately, in the research reported so far little attention has been paid to oral vaccination, which may be of particular importance for the development of protective immunity against enteric parasites. The biggest obstacles to vaccine production at present time are: lack of an efficient expression system, which could guarantee proper post-translational modifications of recombinant helminth antigens as well as lack of efficient mucosal delivery systems. These obstacles will be possibly successfully overcome by use of transgenic plants both for the antigen expression and as adjuvants.

Wydawca

-

Czasopismo

Rocznik

Tom

48

Numer

4

Opis fizyczny

p.239-245,ref.

Twórcy

  • Department of Molecular Biology, W. Stefański Institute of Parasitology, Polish Academy of Sciences, 51-55 Twarda Street, 00-818 Warsaw, Poland
  • Department of Parasitology, Faculty of Veterinary Medicine, Warsaw Agriculture University, 8 Ciszewskiego Street, 02-786 Warszawa, Poland
autor
  • Department of Parasitology, Faculty of Veterinary Medicine, Warsaw Agriculture University, 8 Ciszewskiego Street, 02-786 Warszawa, Poland

Bibliografia

  • Britton C., Murray L. 2002. A cathepsin L protease essential for Caenorhabditis elegans embryogenesis is functionally conserved in parasitic nematodes. Molecular and Biochemical Parasitology, 122,21-33.
  • Broder S., Hotez P.J. 2002. Cures for the Third World’s problems - The application of genomics to the diseases plaguing the developing world may have huge medical and economic benefits for those countries and might even prevent armed conflict. EMBO Reports, 3, 806-812.
  • Cannas A., Naguleswaran A., Muller N., Gottstein B., Hemphill A. 2003. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and Ribi adjuvant. Journal of Parasitology, 89, 44-50.
  • Carmona C., Dowd A.J., Smith A.M., Dalton J.P. 1993. Cathepsin L proteinase secreted by Fasciola hepatica in vitro prevents antibody-mediated eosinophil attachment to newly excysted juveniles. Molecular and Biochemical Parasitology, 62, 9- 18.
  • Charest H., Sedegah M., Yap G.S., Gazzinelli R.T., Caspar P., Hoffman S.L., Sher A. 2000. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8⁺ T cell-dependent protective immunity against malaria. Journal of Immunology, 165, 2084-2092.
  • Claerbout E., Knox D.P., Vercruysse J. 2003. Current research and future prospects in the development of vaccines against gastrointestinal nematodes in cattle. Expert Review of Vaccines. 2, 147-157.
  • Dalton J.P., Brindley P.J., Knox D.P., Brady C.P., Hotez P.J., Donnelly S., O’Neill S.M., Mulcahy G., Loukas A. 2003. Helminth vaccines: from mining genomic information for vaccine targets to systems used for protein expression. International Journal for Parasitology, 33, 621-640.
  • Dalton J.P., McGonigle S., Rolph T.P., Andrews S.J. 1996. Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. Infection and Immunity, 64, 5066- 5074.
  • Donelly J., Berry K., Ulmer J.B. 2003. Technical and regulatory hurdles for DNA vaccines. International Journal for Parasitology, 33, 457—467.
  • Edmonds J.D., Horohov D.W., Chapman M.R., Pourciau S.S., Antoku K., Snedden K., Klei T.R. 2001. Altered immune responses to a heterologous protein in ponies with heavy gastrointestinal parasite burdens. Equine Veterinary Journal, 33, 658-663.
  • Gaucher D., Chadee K. 2003. Prospect for an Entamoeba histolytica Gal-lectin-based vaccine. Parasite Immunology, 25, 55- 58.
  • Harrop S.A. 1995. Characterisation and localization of cathepsin B proteinases expressed by adult A. caninum hookworms. Molecular and Biochemical Parasitology, 71, 163-170.
  • Heath D.D., Jensen O., Lightowlers M.W. 2003. Progress in control of hydatidosis using vaccination - a review of formulation and delivery of the vaccine and recommendations for practical use in control programmes. Acta Tropica, 85, 133-143.
  • Hota-Mitchell S., Clarke M.M., Pooksta R.B., Dekaban G.A. 1999, Recombinant vaccinia virus and gene gun vectors expressing the large subunit of Schistosoma mansoni calpain in a murine immunisation - challenge model. Vaccine, 17, 1338-1354.
  • Hotez P.J., Ashcom J., Bin Z., Bethony J., Williamson A., Hawdon J.M., Jianjun F., Dobardzic A., Rizo I., Bolden J., Jin Q., Yan W., Dobardzic R., Chung-Debose S., Crowell M., Datu B., Delaney A., Dragonovski D., Jiang Y., Liu Y.Y., Ghosh K., Loukas A., Brandt W., Russell P.K., Zook B.C. 2002. Effect of vaccination with recombinant fusion proteins on Ancylostoma caninum habitat selection in the canine intestine. Journal of Parasitology, 88, 684-690.
  • Hotez P.J., Ghosh K., Hawdon J.M., Narasimhan S., Jones B., Shuhua X., Sen L., Bin Z., Haechou X., Hainan R., Heng W., Koski R.A. 1999. Experimental approaches to the development of a recombinant hookworm vaccine. Immunological Reviews, 171, 163-171.
  • Hu M., Chilton N.B., Gasser R.B. 2002. The mitochondrial genomes of the human hookworms, Ancylostoma duodenale and Necator americanus (Nematoda: Secernentea). International Journal for Parasitology, 32, 145-158.
  • Hussein A.S., Kichenin K., Selkirk M.E. 2002. Suppression of secreted acetylcholinesterases expression in Nippostrongylus brasiliensis by RNA interference. Molecular and Biochemical Parasitology, 122,91-94.
  • Knox D., Smith W.D. 2001. Vaccination against gastrointestinal nematodes using gut-expressed antigens. Veterinary Parasitology, 100, 21-32.
  • Kofta W., Mieszczanek J., Płucienniczak G., Wędrychowicz H. 2000. Successful DNA immunisation of rats against fasciolosis. Vaccine, 18, 2985-2990.
  • Kofta W., Wędrychowicz H. 2001. c-DNA vaccination against parasitic infections: advantages and disadvantages. Veterinary Parasitology, 94, 243-247.
  • Lauterslager T.G.M., Florack D.E.A., Wal van der T.J., Molthoff J.W., Langeveld J.P.M., Bosch D., Boersma W.J.A., Hilgers L. A.T. 2001. Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B. Vaccine, 19, 2749-2755.
  • Lauterslager T.G.M., Hilgers L.A.T. 2002. Efficacy of oral administration and oral intake of edible vaccines. Immunology Letters, 84, 185-190.
  • Lavrov D.V., Brown W.M. 2001. Trichinella spiralis mtDNA. A nematode mitochondrial genome that encodes a putative ATP8 and normally structured tRNAs and has a gene arrangement relatable to those of coelomate metazoans. Genetics, 157, 621-637.
  • Le T.H., Blair D., McManus D.P. 2001. Complete DNA sequence and gene organization of the mitochondrial genome of the liverfluke, Fasciola hepatica L. (Platyhelminthes; Trematoda). Parasitology, 123, 609-621.
  • Le T.H., Pearson M.S., Blair D., Dai N., Zhang L.H., McManus D.P. 2002. Complete mitochondrial genomes confirm the distinctiveness of the horse-dog and sheep-dog strains of Echinococcus granulosus. Parasitology, 124, 97-112.
  • Lightowlers M.W., Colebrook A.L., Gauci C.G., Gauci S.M., Kyngdon C.T., Monkhouse J.L., Rodriquez C.V., Read A.J., Rolfe R.A., Sato C. 2003. Vaccination against cestode parasites: anti-helminth vaccines that work and why. Veterinary Parasitology, 115, 83-123.
  • Lightowlers M.W., Rolfe R.A., Gauci C.G. 1996. Taenia saginata: vaccination against cysticercosis in cattle with recombinant oncosphere antigens. Experimental Parasitology, 84, 330- 338.
  • Marsland B.J., Tisdall D.J., Heath D.D., Mercer A.A. 2003. Construction of a recombinant orf virus that expresses an Echinococcus granulosus vaccine antigen from a novel genomic insertion site. Archives of Virology, 148, 555-562.
  • Mieszczanek J., Kofta W., Wędrychowicz H. 2000. Molecular cloning of a cysteine proteinase cDNA from adult Ancylostoma ceylanicum by the method of rapid amplification of cDNA ends using polymerase chain reaction. Parasitology Research, 86, 993-998.
  • Mieszczanek J., Wiśniewski M., Wędrychowicz H. 2001. Isolation of Acey-1 cysteine proteinase recombinant protein and its use in vaccination against Ancylostoma ceylanicum infections. Abstracts of the 18th Conference WAAVP, Stresa 2001, 29.
  • Miller T.A. 1978. Industrial development and field use of the canine hookworm vaccine. Advances in Parasitology, 16, 333-342.
  • Moorthy V., Hill A.V.S. 2002. Malaria vaccines. British Medical Bulletin, 62, 59-72.
  • Morrison C.A., Colin T., Sexton J.L., Bowem F., Wicker J., Friedel T., Spithill T.W. 1996. Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase. Vaccine, 14, 1603-1612.
  • Mulcahy G., O’Connor F., Clery D., Hogan S.R, Dowd A.J., Andrews S. J., Dalton J.P. 1999. Immune responses of cattle to experimental anti -Fasciola hepatica vaccines. Research in Veterinary Science, 67, 27-33.
  • Murray C.J.L., Lopez A.D. 1996. The global burden of disease. Global burden of disease and injury series. WHO 1996.
  • Mutwiri G., Bowersock T., Kidane A., Sanchez M., Gerdts V., Babiuk L.A., Griebel P. 2002. Induction of mucosal immune responses following enteric immunization with antigen delivered in alginate microspheres. Veterinary Immunology and Immunopathology, 87, 269-276.
  • Nakao M., Sako Y., Ito A. 2003. The mitochondrial genome of the tapeworm Taenia solium : A finding of the abbreviated stop codon. Journal of Parasitology, 89, 633-635.
  • Okimoto R., Macfarlane J.L., Wolstenholme D.R. 1990. Evidence for the frequent use of TTG as the translation initiation codon of mitochondrial protein genes in the nematodes, Ascaris suum and Caenorhabditis elegans. Nucleic Acids Research, 18,6113-6118.
  • O’Neill S.M., Mills K.G.H., Dalton J.P. 2001. Fasciola hepatica cathepsin L cysteine proteinase suppresses Bordatella pertussis-specific IFN-γ production in vivo. Parasite Immunology, 23, 541-547.
  • Parkinson J., Whitton C., Guiliano D., Daub J., Blaxter M. 2001. 200,000 nematode expressed sequence tags on the Net. Trends in Parasitology, 17, 394-396.
  • Ramiro M.J., Zarate J.J., Hanke T, Rodriguez D., Rodriguez J.R., Esteban M., Lucientes J., Castillo J.A., Larraga V. 2003. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine, 21, 2474— 2484.
  • Sajid M., McKerrow J.H. 2002. Cysteine proteases of parasitic organisms. Molecular and Biochemical Parasitology, 120, 1-21.
  • Sangster N., Batterham P., Chapman H.D., Duraisingh M., Le Jambre L., Shirley M., Upcroft J., Upcroft P. 2002. Resistance to antiparasitic drags: the role of molecular diagnosis. International Journal for Parasitology, 32, 637-653.
  • Sexton J.L., Wilce M.C., Colin T., Wijffels G.L., Salvatore L., Feil S., Parker M.W., Spithill T.W., Morrison C.A. 1994. Vaccination of sheep against Fasciola hepatica with glutathione S-transferase. Identification and mapping of three-dimensional model of the antigen. Journal of Immunology, 152, 1861- 1872.
  • Singh M., O’Hagan D.T. 2003. Recent advances in veterinary vaccine adjuvants. International Journal for Parasitology, 33, 469-478.
  • Spithill T.W., Dalton J.P. 1998. Progress in development of liver fluke vaccines. Parasitology Today, 14, 224-228.
  • Streatfield S.J., Howard J.A. 2003. Plant-based vaccines. International Journal for Parasitology, 33, 479-493.
  • Taylor M.A., Hunt K.R., Goodyear K.L. 2002. Anthelmintic resistance detection methods. Veterinary Parasitology, 103, 183— 194.
  • Tort J., Brindley P.J., Knox D., Wolfe K.H., Dalton J.P. 1999. Proteinases and associated genes of parasitic helminths. Advances in Parasitology, 43, 162-266.
  • Tsuji N., Suzuki K., Kasuga-Aoki H., Isobe T., Arakawa T., Matsumoto Y. 2003. Mice intranasally immunized with a recombinant 16-kilodalton antigen from roundworm Ascaris parasites are protected against larval migration of Ascaris suum. Infection and Immunity, 71, 5314-5323.
  • Wędrychowicz H., Lamparska M., Kęsik M., Kotomski G., Mieszczanek J., Jedlina-Panasiuk L., Płucienniczak A. 2003. The immune response of rats to vaccination with the cDNA or protein forms of the cysteine proteinase of Fasciola hepatica. Veterinary Immunology and Immunopathology, 94, 83- 93.
  • Wędrychowicz H., Szymański P., Jedlina-Panasiuk L., Bieńkowska- Szewczyk K. 2002. Humoral immune response of rats vaccinated with cDNA or protein form of glutathione-S-transferase of Fasciola hepatica to infection with metacercariae of the fluke. Helminthologia, 39, 127-133.
  • Wijffels G.L., Salvatore L., Dosen M., Waddington J., Wilson L., Thompson C., Campbell N., Sexton J., Wicker J., Bowen F. 1994. Vaccination of sheep with purified cysteine proteinases of Fasciola hepatica decreases worm fecundity. Experimental Parasitology, 78, 132-148.
  • Willadsen P., Bird P.E., Cobon G., Hungerford J. 1995. Commercialization of a recombinant vaccine against Boophilus microplus. Parasitology, 110, S43-S50.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-28733fd0-1792-42af-9f23-8a063ad250fa
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.